417 related articles for article (PubMed ID: 28622731)
41. Technology Transfer of the Microphysiological Systems: A Case Study of the Human Proximal Tubule Tissue Chip.
Sakolish C; Weber EJ; Kelly EJ; Himmelfarb J; Mouneimne R; Grimm FA; House JS; Wade T; Han A; Chiu WA; Rusyn I
Sci Rep; 2018 Oct; 8(1):14882. PubMed ID: 30291268
[TBL] [Abstract][Full Text] [Related]
42. A Historical View and Vision into the Future of the Field of Safety Pharmacology.
Bass AS; Hombo T; Kasai C; Kinter LB; Valentin JP
Handb Exp Pharmacol; 2015; 229():3-45. PubMed ID: 26091634
[TBL] [Abstract][Full Text] [Related]
43. Human biomimetic liver microphysiology systems in drug development and precision medicine.
Gough A; Soto-Gutierrez A; Vernetti L; Ebrahimkhani MR; Stern AM; Taylor DL
Nat Rev Gastroenterol Hepatol; 2021 Apr; 18(4):252-268. PubMed ID: 33335282
[TBL] [Abstract][Full Text] [Related]
44. Navigating the Future of Cardiovascular Drug Development-Leveraging Novel Approaches to Drive Innovation and Drug Discovery: Summary of Findings from the Novel Cardiovascular Therapeutics Conference.
Povsic TJ; Scott R; Mahaffey KW; Blaustein R; Edelberg JM; Lefkowitz MP; Solomon SD; Fox JC; Healy KE; Khakoo AY; Losordo DW; Malik FI; Monia BP; Montgomery RL; Riesmeyer J; Schwartz GG; Zelenkofske SL; Wu JC; Wasserman SM; Roe MT
Cardiovasc Drugs Ther; 2017 Aug; 31(4):445-458. PubMed ID: 28735360
[TBL] [Abstract][Full Text] [Related]
45. Liver microphysiological systems development guidelines for safety risk assessment in the pharmaceutical industry.
Baudy AR; Otieno MA; Hewitt P; Gan J; Roth A; Keller D; Sura R; Van Vleet TR; Proctor WR
Lab Chip; 2020 Jan; 20(2):215-225. PubMed ID: 31799979
[TBL] [Abstract][Full Text] [Related]
46. Equipment and analytical companies meeting continuous challenges. May 20-21, 2014 Continuous Manufacturing Symposium.
Page T; Dubina H; Fillipi G; Guidat R; Patnaik S; Poechlauer P; Shering P; Guinn M; Mcdonnell P; Johnston C
J Pharm Sci; 2015 Mar; 104(3):821-31. PubMed ID: 25448273
[TBL] [Abstract][Full Text] [Related]
47. Liver and Kidney on Chips: Microphysiological Models to Understand Transporter Function.
Chang SY; Weber EJ; Ness KV; Eaton DL; Kelly EJ
Clin Pharmacol Ther; 2016 Nov; 100(5):464-478. PubMed ID: 27448090
[TBL] [Abstract][Full Text] [Related]
48. The NCI All Ireland Cancer Conference.
Johnston PG; Daly PA; Liu E
Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
[TBL] [Abstract][Full Text] [Related]
49. Tissue Chips and Microphysiological Systems for Disease Modeling and Drug Testing.
Donoghue L; Nguyen KT; Graham C; Sethu P
Micromachines (Basel); 2021 Jan; 12(2):. PubMed ID: 33525451
[TBL] [Abstract][Full Text] [Related]
50. Emerging technologies for prediction of drug candidate efficacy in the preclinical pipeline.
Menshykau D
Drug Discov Today; 2017 Nov; 22(11):1598-1603. PubMed ID: 28545837
[TBL] [Abstract][Full Text] [Related]
51. Monitoring of Microphysiological Systems: Integrating Sensors and Real-Time Data Analysis toward Autonomous Decision-Making.
Young AT; Rivera KR; Erb PD; Daniele MA
ACS Sens; 2019 Jun; 4(6):1454-1464. PubMed ID: 30964652
[TBL] [Abstract][Full Text] [Related]
52. Organs-on-chips: into the next decade.
Low LA; Mummery C; Berridge BR; Austin CP; Tagle DA
Nat Rev Drug Discov; 2021 May; 20(5):345-361. PubMed ID: 32913334
[TBL] [Abstract][Full Text] [Related]
53. Gastrointestinal microphysiological systems.
Blutt SE; Broughman JR; Zou W; Zeng XL; Karandikar UC; In J; Zachos NC; Kovbasnjuk O; Donowitz M; Estes MK
Exp Biol Med (Maywood); 2017 Oct; 242(16):1633-1642. PubMed ID: 28534432
[TBL] [Abstract][Full Text] [Related]
54. Cell chips as new tools for cell biology--results, perspectives and opportunities.
Primiceri E; Chiriacò MS; Rinaldi R; Maruccio G
Lab Chip; 2013 Oct; 13(19):3789-802. PubMed ID: 23912640
[TBL] [Abstract][Full Text] [Related]
55. Facilitating the commercialization and use of organ platforms generated by the microphysiological systems (Tissue Chip) program through public-private partnerships.
Livingston CA; Fabre KM; Tagle DA
Comput Struct Biotechnol J; 2016; 14():207-210. PubMed ID: 27904714
[TBL] [Abstract][Full Text] [Related]
56. Advances in microfluidics for drug discovery.
Lombardi D; Dittrich PS
Expert Opin Drug Discov; 2010 Nov; 5(11):1081-94. PubMed ID: 22827746
[TBL] [Abstract][Full Text] [Related]
57. Tissue chips - innovative tools for drug development and disease modeling.
Low LA; Tagle DA
Lab Chip; 2017 Sep; 17(18):3026-3036. PubMed ID: 28795174
[TBL] [Abstract][Full Text] [Related]
58. Organs-on-a-Chip.
Moyer MW
Sci Am; 2011 Mar; 304(3):19. PubMed ID: 21438480
[No Abstract] [Full Text] [Related]
59. Preclinical pharmacokinetic/pharmacodynamic modeling and simulation in the pharmaceutical industry: an IQ consortium survey examining the current landscape.
Schuck E; Bohnert T; Chakravarty A; Damian-Iordache V; Gibson C; Hsu CP; Heimbach T; Krishnatry AS; Liederer BM; Lin J; Maurer T; Mettetal JT; Mudra DR; Nijsen MJ; Raybon J; Schroeder P; Schuck V; Suryawanshi S; Su Y; Trapa P; Tsai A; Vakilynejad M; Wang S; Wong H
AAPS J; 2015 Mar; 17(2):462-73. PubMed ID: 25630504
[TBL] [Abstract][Full Text] [Related]
60. Application of microfluidic chips in anticancer drug screening.
Fan XY; Deng ZF; Yan YY; E Orel V; Shypko A; B Orel V; Ivanova D; Pilarsky C; Tang J; Chen ZS; Zhang JY
Bosn J Basic Med Sci; 2022 Jun; 22(3):302-314. PubMed ID: 34627135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
